1 – 10 of 1268
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE) : a cost minimisation analysis
- Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism : Prospective results from the EMAS
- Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial
- Comparison of DEXA and Bioimpedance for Body Composition Measurements in Nondialysis Patients With CKD
- Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis : Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene
- Pharmacotherapy for Nocturia
- GFR-gränsen har sänkts för metformin vid typ 2-diabetes : Nya rekommendationer vid nedsatt njurfunktion och undersökning med jodkontrastmedel
- Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer
- Levels of DNA damage (Micronuclei) in patients suffering from chronic kidney disease. Role of GST polymorphisms
- Maximally effective dosing regimens of meropenem in patients with septic shock